Golden State Wealth Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History
Golden State Wealth Management, LLC
- $906 Billion
- Q3 2025
A detailed history of Golden State Wealth Management, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 66 shares of RARE stock, worth $2,142. This represents 0.0% of its overall portfolio holdings.
Number of Shares
66Holding current value
$2,142% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RARE
# of Institutions
361Shares Held
86.8MCall Options Held
3.64MPut Options Held
2.24M-
Vanguard Group Inc Valley Forge, PA10.2MShares$332 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$182 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.94MShares$128 Million0.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.89MShares$93.7 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY2.77MShares$90 Million1.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.27B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...